0000950170-24-076867.txt : 20240624 0000950170-24-076867.hdr.sgml : 20240624 20240624170622 ACCESSION NUMBER: 0000950170-24-076867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dadoo Rajeev CENTRAL INDEX KEY: 0001951685 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39756 FILM NUMBER: 241065203 MAIL ADDRESS: STREET 1: C/O ARS PHARMACEUTICALS, INC. STREET 2: 11682 EL CAMINO REAL, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001671858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-771-9307 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Silverback Therapeutics, Inc. DATE OF NAME CHANGE: 20160412 4 1 ownership.xml 4 X0508 4 2024-06-20 0001671858 ARS Pharmaceuticals, Inc. SPRY 0001951685 Dadoo Rajeev 985 OLD EAGLE SCHOOL ROAD SUITE 511 WAYNE PA 19087 true false false false false Stock Option (right to buy) 7.73 2024-06-20 4 A false 40000 0 A 2034-06-19 Common Stock 40000 40000 D The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. /s/ Sasha Keough, attorney-in-fact for Rajeev Dadoo 2024-06-24